{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:35:12Z","timestamp":1791999312114,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jcin.2025.08.041","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:35:38Z","timestamp":1762864538000},"page":"2629-2637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["3-Year Results Following Femoropopliteal Lesion Treatment With a Novel Sirolimus-Eluting Balloon"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1931-5769","authenticated-orcid":false,"given":"Yoshimitsu","family":"Soga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-4079","authenticated-orcid":false,"given":"Shigeo","family":"Ichihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daizo","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terutoshi","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-9220","authenticated-orcid":false,"given":"Masahiko","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9107-6438","authenticated-orcid":false,"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amane","family":"Kozuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcin.2025.08.041_bib1","first-page":"124","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions","volume":"92","author":"Feldman","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.jcin.2025.08.041_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2025.08.041_bib3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","article-title":"Acotec drug-coated balloon catheter","volume":"9","author":"Jia","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.08.041_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.08.041_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.08.041_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2025.08.041_bib7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-Year results from the RANGER II SFA randomized trial of the Ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.08.041_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjcard.2020.05.015","article-title":"Meta-analysis comparing endovascular treatment modalities for femoropopliteal peripheral artery disease","volume":"128","author":"Khan","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2025.08.041_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s42155-022-00308-z","article-title":"Utility of sirolimus coated balloons in the peripheral vasculature - a review of the current literature","volume":"5","author":"Linn","year":"2022","journal-title":"CVIR Endovasc"},{"issue":"2","key":"10.1016\/j.jcin.2025.08.041_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/jcm14020483","article-title":"Real-world 12-month outcomes with sirolimus-coated balloon angioplasty for complex femoropopliteal disease","volume":"14","author":"Beropoulis","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcin.2025.08.041_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/fca-2020-0085","article-title":"The SELUTION SLR drug-eluting balloon system for the treatment of symptomatic femoropopliteal lesions","volume":"17","author":"Bohme","year":"2021","journal-title":"Future Cardiol"},{"key":"10.1016\/j.jcin.2025.08.041_bib12","article-title":"Combination therapy using scoring and sirolimus drug-coated balloons during lower limb endovascular revascularization for chronic limb threatening ischaemia: a case series","volume":"10","author":"Bong","year":"2022","journal-title":"SAGE Open Med Case Rep"},{"issue":"5","key":"10.1016\/j.jcin.2025.08.041_bib13","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1177\/15266028231217657","article-title":"Sirolimus-coated balloon in femoropopliteal steno-occlusive disease: efficacy, safety, and 1-year outcomes. an all-comers registry","volume":"32","author":"Franzese","year":"2025","journal-title":"J Endovasc Ther"},{"issue":"13","key":"10.1016\/j.jcin.2025.08.041_bib14","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.jcin.2024.03.029","article-title":"A novel sirolimus-coated balloon for the treatment of femoropopliteal lesions: the SELUTION SFA Japan trial","volume":"17","author":"Iida","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.08.041_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00270-024-03756-3","article-title":"The utility of sirolimus eluting balloons in the setting of chronic limb threatening ischaemia in Asian patients from Singapore - 12 months results of the PRISTINE registry","volume":"47","author":"Tang","year":"2024","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2025.08.041_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/15266028211007457","article-title":"World's first experience treating TASC II C and D tibial occlusive disease using the Selution SLR sirolimus-eluting balloon: six-month results from the PRESTIGE study","volume":"28","author":"Tang","year":"2021","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jcin.2025.08.041_bib17","series-title":"A novel sustained limus release eluting balloon: 2-year data from the SELUTION SFA trial","author":"Zeller","year":"2019"},{"key":"10.1016\/j.jcin.2025.08.041_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1526602820941811","article-title":"Six-month outcomes from the first-in-human, single-arm SELUTION sustained-limus-release drug-eluting balloon trial in femoropopliteal lesions","volume":"27","author":"Zeller","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jcin.2025.08.041_bib19","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/15266028211064816","article-title":"MagicTouch PTA sirolimus coated balloon for femoropopliteal and below the knee disease: results from XTOSI pilot study up to 12 months","volume":"29","author":"Choke","year":"2022","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jcin.2025.08.041_bib20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2025.08.041_bib21","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.jcin.2022.08.004","article-title":"Low-dose vs high-dose paclitaxel-coated balloons for femoropopliteal lesions: 2-year results from the COMPARE trial","volume":"15","author":"Steiner","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.08.041_bib22","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.jcin.2023.08.022","article-title":"Low-dose vs high-dose drug-coated balloon for symptomatic femoropopliteal artery disease: the PROSPECT MONSTER study outcomes","volume":"16","author":"Nakama","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.08.041_bib23","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/CIRCULATIONAHA.110.936922","article-title":"Drug-coated balloons for the prevention of vascular restenosis","volume":"121","author":"Gray","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.08.041_bib24","first-page":"664","article-title":"Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial","volume":"93","author":"Iida","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.08.041_bib25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/1526602820948240","article-title":"Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty","volume":"27","author":"Soga","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jcin.2025.08.041_bib26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/1358863X241228261","article-title":"Three-year clinical course after fluoropolymer-based drug-eluting stent implantation for femoropopliteal lesions","volume":"29","author":"Iida","year":"2024","journal-title":"Vasc Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193687982502432X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193687982502432X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:43:02Z","timestamp":1786027382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193687982502432X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S193687982502432X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2025.08.041","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3-Year Results Following Femoropopliteal Lesion Treatment With a Novel Sirolimus-Eluting Balloon","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2025.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}